Sultana Chowdhury became a victim of the infected blood scandal after giving birth. But she wasn’t diagnosed until 24 years later. Her family believe she might have been treated differently because of her Bangladeshi heritage. fatimamanji reports.
When Sultana Chowdhury gave birth in 1987, she needed a blood transfusion. The blood she was given was infected with Hepatitis C – and she became a victim of what’s described as one of the worst treatment disasters in the history of the NHS.
But unlike many victims of the infected blood scandal of the ‘70s and ‘80s, Sultana lived for years without ever being diagnosed. The cause of her ill health was not determined until 24 years later, and not in time to effectively manage the illness, which took her life in August.Warning, this report contains distressing themes.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Woody Harrelson drank actual cobra blood with Michael J Fox in the 1980sWoody Harrelson has revealed quite gruesome details from a decades-ago trip with Michael J Fox, and it involves the pair drinking actual cobra blood. Yep. Cobra blood 🐍
Read more »
Study finds strong causal link between diastolic blood pressure and neurotic personality traitDiastolic blood pressure—the lower of the two numbers in a blood pressure reading—is highly likely to cause neurotic personality trait, finds research published in General Psychiatry.
Read more »
Additional mRNA COVID vaccine doses could salvage antibody responses in blood cancer patientsAdditional mRNA COVID vaccine doses could salvage antibody responses in blood cancer patients Antibody Blood BloodCancer Cancer Coronavirus Disease COVID Vaccine NatureComms imperialcollege
Read more »
Intestinal microorganisms influence white blood cell levels, study findsIntestinal bacteria composition is crucial to driving the recovery of neutrophil counts in the blood of mice following treatments such as stem cell transplants or chemotherapy.
Read more »
Evaluating cell-free DNA-based blood tests for early detection of multiple cancersResearchers assessed several approaches for a circulating cell-free deoxyribonucleic acid (cfDNA)-based multi-cancer early detection (MCED) test. Defining the clinical limit of detection (LOD) based on circulating tumor allele fraction (cTAF) enables the comparison of different approaches.
Read more »